ask="22.49"
ask_size="100"
average_daily_volume="75242"
bid="14.25"
bid_size="400"
book_value="-91.82"
change="+2.84"
change_from_200_day_moving_average="7.56"
change_from_50_day_moving_average="6.05"
change_from_52_week_high="-0.33"
change_From_52_week_low="10.10"
change_in_percent="+14.71%"
close="22.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-41.42"
ebitda="-20.24M"
eps_estimate_current_year="-2.50"
eps_estimate_next_quarter="-0.43"
eps_estimate_next_year="-1.93"
ex_dividend_date="N/A"
float_shares="8856000"
high="22.48"
high_52_weeks="22.48"
last_trade_date="2/10/2017"
last_trade_price="22.15"
last_trade_size="5186"
last_trade_time="4:00pm"
low="19.22"
low_52_weeks="12.05"
market_capitalization="499.39M"
moving_average_200_day="14.59"
moving_average_50_day="16.10"
name="Ra Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="25.50"
open="19.73"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+51.78%"
percent_change_from_50_day_moving_average="+37.62%"
percent_change_from_52_week_high="-1.47%"
percent_change_from_52_week_low="+83.80%"
previous_close="19.31"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="75.73"
revenue="5.75M"
shares_outstanding="22546000"
short_ratio="3.28"
stock_exchange="NGM"
symbol="RARX"
volume="91554"
weeks_range_52="12.05 - 22.48"
